Literature DB >> 20694126

Duloxetine may improve some symptoms of attention-deficit/hyperactivity disorder.

Helmut Niederhofer.   

Abstract

Entities:  

Year:  2010        PMID： 20694126      PMCID： PMC2910994          DOI： 10.4088/PCC.09l00807pin

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  13 in total

1.  A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.

Authors:  D F Connor; K E Fletcher; J M Swanson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-12       Impact factor: 8.829

2.  Analog classroom assessment of Adderall in children with ADHD.

Authors:  J M Swanson; S Wigal; L L Greenhill; R Browne; B Waslik; M Lerner; L Williams; D Flynn; D Agler; K Crowley; E Fineberg; M Baren; D P Cantwell
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-05       Impact factor: 8.829

3.  SAFTEE: a technique for the systematic assessment of side effects in clinical trials.

Authors:  J Levine; N R Schooler
Journal:  Psychopharmacol Bull       Date:  1986

4.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.

Authors:  L L Greenhill; H B Abikoff; L E Arnold; D P Cantwell; C K Conners; G Elliott; L Hechtman; S P Hinshaw; B Hoza; P S Jensen; J S March; J Newcorn; W E Pelham; J B Severe; J M Swanson; B Vitiello; K Wells
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-10       Impact factor: 8.829

5.  Bupropion hydrochloride in attention deficit disorder with hyperactivity.

Authors:  C K Conners; C D Casat; C T Gualtieri; E Weller; M Reader; A Reiss; R A Weller; M Khayrallah; J Ascher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-10       Impact factor: 8.829

6.  Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Robert L Findling; Laurence L Greenhill; Nora K McNamara; Christine A Demeter; Lisa A Kotler; Mary Ann O'Riordan; Carolyn Myers; Michael D Reed
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-08       Impact factor: 2.576

7.  Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.

Authors:  M D Rapport; C Denney; G J DuPaul; M J Gardner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Jul-Aug       Impact factor: 8.829

8.  Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine.

Authors:  Sunmee Wee; William L Woolverton
Journal:  Drug Alcohol Depend       Date:  2004-09-06       Impact factor: 4.492

9.  Clonidine in Tourette's syndrome.

Authors:  D J Cohen; J G Young; J A Nathanson; B A Shaywitz
Journal:  Lancet       Date:  1979-09-15       Impact factor: 79.321

10.  The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

Authors:  H S Singer; J Brown; S Quaskey; L A Rosenberg; E D Mellits; M B Denckla
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.